查找临床试验

已按「脂肪肝」检索,对应国际通用词 metabolic dysfunction-associated steatohepatitis

试验不在中国怎么办?

共找到 26 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 23:03,每 5 分钟自动同步
正在招募III 期中国有中心NCT06419374

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

United States、Argentina、Australia、Belgium、Brazil 等 12 国

年龄 18 Years – 75 Years

Hoffmann-La Roche

正在招募I 期中国有中心NCT07807059

A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment

China

年龄 18 Years – 65 Years

Fujian Shengdi Pharmaceutical Co., Ltd.

正在招募II 期中国有中心NCT07145151

A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

China

年龄 18 Years – 75 Years

The United Bio-Technology (Hengqin) Co., Ltd.

正在招募III 期中国有中心NCT07581951

A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH

China

年龄 18 Years – 不限

Haisco Pharmaceutical Group Co., Ltd.

正在招募不适用中国有中心NCT07632677

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

China

年龄 18 Years – 不限

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

正在招募III 期中国有中心NCT06318169

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

United States、Argentina、Australia、Austria、Belgium 等 12 国

年龄 18 Years – 80 Years

Hoffmann-La Roche

正在招募I 期中国有中心NCT07803809

Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

China

年龄 18 Years – 50 Years

Shanghai Minwei Biotechnology Co., Ltd

正在招募不适用中国有中心NCT06717828

The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults

China

年龄 40 Years – 75 Years

Fujian Provincial Hospital

正在招募不适用中国有中心NCT06939569

An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

China

年龄 18 Years – 不限

Shanghai East Hospital

正在招募II 期中国有中心NCT07660848

A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis

China

年龄 18 Years – 75 Years

Fujian Shengdi Pharmaceutical Co., Ltd.

正在招募IV 期中国有中心NCT07718126

Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

China

年龄 18 Years – 60 Years

West China Hospital

正在招募不适用中国有中心NCT07070362

Digital Early Warning System for Acute Lung Injury in Liver Surgery

China

年龄 18 Years – 不限

Beijing Tsinghua Chang Gung Hospital